Literature DB >> 35039980

Circ_0000467 Exerts an Oncogenic Role in Colorectal Cancer via miR-330-5p-Dependent Regulation of TYRO3.

Yubao Huang1, Zhiyu Chen2, Xiong Zhou2, Hai Huang2.   

Abstract

Colorectal cancer (CRC) remains one of the most frequent neoplasms of digestive tract worldwide. Circular RNAs (circRNAs) have been identified to serve crucial regulatory roles in the pathogenesis of human cancers. However, the role and regulatory mechanism of circ_0000467 in the progression of CRC are still unclear. The expression levels of circ_0000467, microRNA-330-5p (miR-330-5p), and tyrosine receptor kinase 3 (TYRO3) were measured by quantitative real-time polymerase chain reaction (qRT-PCR). The interaction between miR-330-5p and circ_0000467 or TYRO3 was validated by dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay. Xenograft tumor assay and Immunohistochemistry (IHC) assay were implemented to analyze CRC tumor growth in vivo. Circ_0000467 was a stable circRNA and was highly expressed in CRC tumor tissues and cells. Silencing of circ_0000467 could inhibit the proliferation, migration, invasion, and glycolysis and accelerated the apoptosis of CRC cells in vitro and hindered tumor growth in vivo. Mechanistically, circ_0000467 directly interacted with miR-330-5p and circ_0000467 depletion inhibited CRC cell malignant progression by regulating miR-330-5p. Furthermore, TYRO3 was a target of miR-330-5p and circ_0000467 upregulated TYRO3 expression by sponging miR-330-5p. Moreover, TYRO3 overexpression counteracted the inhibitory effect of miR-330-5p overexpression or circ_0000467 knockdown on CRC cell progression. Altogether, circ_0000467 knockdown suppressed CRC cell malignant development through modulating the miR-330-5p/TYRO3 network, providing a novel molecular target of CRC therapy.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CRC; Glycolysis; Progression; TYRO3; circ_0000467; miR-330-5p

Mesh:

Substances:

Year:  2022        PMID: 35039980     DOI: 10.1007/s10528-021-10171-7

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   2.220


  5 in total

1.  EGFR/PPARδ/HSP90 pathway mediates cancer cell metabolism and chemoresistance.

Authors:  Qian Gou; Wenbo Zhang; Ying Xu; Jianhua Jin; Qian Liu; Yongzhong Hou; Juanjuan Shi
Journal:  J Cell Biochem       Date:  2020-11-08       Impact factor: 4.429

Review 2.  MicroRNAome genome: a treasure for cancer diagnosis and therapy.

Authors:  Ioana Berindan-Neagoe; Paloma del C Monroig; Barbara Pasculli; George A Calin
Journal:  CA Cancer J Clin       Date:  2014-08-07       Impact factor: 508.702

3.  LINC00337 promotes tumor angiogenesis in colorectal cancer by recruiting DNMT1, which suppresses the expression of CNN1.

Authors:  Xiangming Xu; Jiao Nie; Lin Lu; Chao Du; Fansheng Meng; Duannuo Song
Journal:  Cancer Gene Ther       Date:  2020-12-16       Impact factor: 5.987

4.  MicroRNA-7 inhibits colorectal cancer cell proliferation, migration and invasion via TYRO3 and phosphoinositide 3-kinase/protein B kinase/mammalian target of rapamycin pathway suppression.

Authors:  Ancheng Qin; Weifeng Qian
Journal:  Int J Mol Med       Date:  2018-09-07       Impact factor: 4.101

5.  Circular RNA hsa_circ_0000467 Promotes the Development of Gastric Cancer by Competitively Binding to MicroRNA miR-326-3p.

Authors:  Wei Lie Mo; Jing Ting Jiang; Luo Zhang; Qi Cheng Lu; Jing Li; Wei Dong Gu; Yun Cheng; Hai Tao Wang
Journal:  Biomed Res Int       Date:  2020-02-06       Impact factor: 3.411

  5 in total
  1 in total

Review 1.  MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy.

Authors:  Janusz Matuszyk
Journal:  Mol Med       Date:  2022-08-03       Impact factor: 6.376

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.